Advertisement

Month: August 2012

FDA Approves Lucentis for Diabetic Macular Edema

Genentech, a member of the Roche Group, today announced that Lucentis® (ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment of diabetic macular edema (DME), an eye condition in...

Read More

For latest news and updates
Email-id is invalid